Literature DB >> 15538384

Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.

Yukiyo Tateishi1, Yoh-ichi Kawabe, Tomoki Chiba, Shigeo Murata, Ken Ichikawa, Akiko Murayama, Keiji Tanaka, Tadashi Baba, Shigeaki Kato, Junn Yanagisawa.   

Abstract

Recent evidence indicates that the transactivation of estrogen receptor alpha (ERalpha) requires estrogen-dependent receptor ubiquitination and degradation. Here we show that estrogen-unbound (unliganded) ERalpha is also ubiquitinated and degraded through a ubiquitin-proteasome pathway. To investigate this ubiquitin-proteasome pathway, we purified the ubiquitin ligase complex for unliganded ERalpha and identified a protein complex containing the carboxyl terminus of Hsc70-interacting protein (CHIP). CHIP preferentially bound to misfolded ERalpha and ubiquitinated it to induce degradation. Ligand binding to the receptor induced the dissociation of CHIP from ERalpha. In CHIP-/- cells, the degradation of unliganded ERalpha was abrogated; however, estrogen-induced degradation was observed to the same extent as in CHIP+/+ cells. Our findings suggest that ERalpha is regulated by two independent ubiquitin-proteasome pathways, which are switched by ligand binding to ERalpha. One pathway is necessary for the transactivation of the receptor and the other is involved in the quality control of the receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538384      PMCID: PMC535086          DOI: 10.1038/sj.emboj.7600472

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

Review 1.  Posttranslational quality control: folding, refolding, and degrading proteins.

Authors:  S Wickner; M R Maurizi; S Gottesman
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine.

Authors:  C Scheufler; A Brinker; G Bourenkov; S Pegoraro; L Moroder; H Bartunik; F U Hartl; I Moarefi
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

3.  The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.

Authors:  Z Nawaz; D M Lonard; C L Smith; E Lev-Lehman; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 4.  Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function.

Authors:  M E Cheetham; A J Caplan
Journal:  Cell Stress Chaperones       Date:  1998-03       Impact factor: 3.667

5.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

6.  Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions.

Authors:  C A Ballinger; P Connell; Y Wu; Z Hu; L J Thompson; L Y Yin; C Patterson
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  Proteasome-dependent degradation of the human estrogen receptor.

Authors:  Z Nawaz; D M Lonard; A P Dennis; C L Smith; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

Authors:  D M Lonard; Z Nawaz; C L Smith; B W O'Malley
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

Review 9.  A decade of molecular biology of retinoic acid receptors.

Authors:  P Chambon
Journal:  FASEB J       Date:  1996-07       Impact factor: 5.191

10.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

View more
  63 in total

1.  Aptamer-Enabled Manipulation of the Hsp70 Chaperone System Suggests a Novel Strategy for Targeted Ubiquitination.

Authors:  Deepak Thirunavukarasu; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2015-12-07       Impact factor: 5.486

2.  Tumor suppressor function of RUNX3 in breast cancer.

Authors:  Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

3.  Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis.

Authors:  Yukiyo Tateishi; Raku Sonoo; Yu-ichi Sekiya; Nanae Sunahara; Miwako Kawano; Mitsutoshi Wayama; Ryuichi Hirota; Yoh-ichi Kawabe; Akiko Murayama; Shigeaki Kato; Keiji Kimura; Junn Yanagisawa
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

4.  Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.

Authors:  Christopher C Valley; Raphaël Métivier; Natalia M Solodin; Amy M Fowler; Mara T Mashek; Lindsay Hill; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Authors:  Olga Ch Kousidou; Aikaterini Berdiaki; Dimitris Kletsas; Alexandros Zafiropoulos; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

6.  Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation.

Authors:  Elena Kamynina; Krista Kauppinen; Faping Duan; Nora Muakkassa; Danny Manor
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

7.  Cadmium and Secondary Structure-dependent Function of a Degron in the Pca1p Cadmium Exporter.

Authors:  Nathan Smith; Wenzhong Wei; Miaoyun Zhao; Xiaojuan Qin; Javier Seravalli; Heejeong Kim; Jaekwon Lee
Journal:  J Biol Chem       Date:  2016-04-08       Impact factor: 5.157

8.  Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

Authors:  Ichiaki Ito; Aki Hanyu; Mitsutoshi Wayama; Natsuka Goto; Yoko Katsuno; Shohei Kawasaki; Yuka Nakajima; Masashi Kajiro; Yoko Komatsu; Akiko Fujimura; Ryuichi Hirota; Akiko Murayama; Keiji Kimura; Takeshi Imamura; Junn Yanagisawa
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

9.  Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.

Authors:  Nicholas B Berry; Meiyun Fan; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2008-04-03

10.  Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites.

Authors:  Christian Atsriku; David J Britton; Jason M Held; Birgit Schilling; Gary K Scott; Bradford W Gibson; Christopher C Benz; Michael A Baldwin
Journal:  Mol Cell Proteomics       Date:  2008-11-03       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.